HIMS:NYE-Hims Hers Health Inc (USD)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 29.81

Change

+1.96 (+7.04)%

Market Cap

USD 5.50B

Volume

0.01B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-21 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
UL Unilever PLC ADR

+1.25 (+2.25%)

USD 137.66B
KMB Kimberly-Clark Corporation

-0.70 (-0.55%)

USD 42.43B
CHD Church & Dwight Company Inc

+0.19 (+0.18%)

USD 26.08B
CLX The Clorox Company

-0.29 (-0.18%)

USD 19.50B
ELF ELF Beauty Inc

-8.46 (-6.66%)

USD 7.15B
COTY Coty Inc

+0.15 (+2.10%)

USD 6.26B
SPB Spectrum Brands Holdings Inc

+0.62 (+0.72%)

USD 2.34B
EPC Edgewell Personal Care Co

+0.21 (+0.62%)

USD 1.54B
PZC PIMCO California Municipal Inc..

+0.02 (+0.30%)

USD 0.63B
YSG Yatsen Holding

+0.08 (+2.37%)

USD 0.31B

ETFs Containing HIMS

EDOC:AU BetaShares Digital Health.. 6.74 % 0.00 %

N/A

N/A
PTH Invesco DWA Healthcare Mo.. 6.58 % 0.60 %

+1.47 (+1.27%)

USD 0.12B
DDOC:F Global X Telemedicine & D.. 5.68 % 0.00 %

N/A

USD 4.62M
EDOC Global X Telemedicine & D.. 5.08 % 0.00 %

+0.32 (+1.27%)

USD 0.04B
EDOC:LSE Global X Telemedicine & D.. 4.66 % 0.00 %

+0.08 (+1.27%)

USD 2.18M
EDOG:LSE Global X Telemedicine & D.. 4.66 % 0.00 %

+0.07 (+1.27%)

USD 0.48M
EDOC:SW Global X Telemedicine & D.. 4.40 % 0.00 %

+0.08 (+1.27%)

N/A
ULTY Tidal Trust II 3.47 % 0.00 %

+0.11 (+1.27%)

USD 0.28B
PSCH Invesco S&P SmallCap Heal.. 3.33 % 0.29 %

+1.19 (+1.27%)

USD 0.18B
FNY First Trust Mid Cap Growt.. 0.82 % 0.70 %

+1.55 (+1.27%)

USD 0.39B
ETLZ:XETRA L&G Russell 2000 US Small.. 0.60 % 0.00 %

+0.12 (+1.27%)

USD 0.09B
FNX First Trust Mid Cap Core .. 0.41 % 0.62 %

+1.72 (+1.27%)

USD 1.28B
FFTY Innovator IBD® 50 ETF 0.00 % 0.80 %

+0.98 (+1.27%)

N/A
IBUY Amplify Online Retail ETF 0.00 % 0.65 %

+0.48 (+1.27%)

USD 0.18B
RTWO:LSE L&G Russell 2000 US Small.. 0.00 % 0.00 %

+0.03 (+1.27%)

USD 0.23B
RTWP:LSE Legal & General UCITS ETF.. 0.00 % 0.00 %

+8.50 (+1.27%)

USD 0.23B
DDOC:XETRA Global X Telemedicine & D.. 0.00 % 0.00 %

+0.10 (+1.27%)

USD 5.39M

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.28% 100% F 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.28% 100% F 98% N/A
Trailing 12 Months  
Capital Gain 240.69% 100% F 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 240.69% 100% F 99% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 38.83% 88% B+ 91% A-
Dividend Return 38.83% 76% C+ 90% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 82.78% 12% F 11% F
Risk Adjusted Return 46.91% 65% D 61% D-
Market Capitalization 5.50B 54% F 79% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.